There are 2773 resources available
1724P - Prognostic parameters at admission as predictors of hospital length of stay (HLOS) and overall survival (OS) in hospitalized oncologic patients (pts) of a tertiary hospital
Presenter: Oriol Mirallas
Session: ePoster Display
1725P - Outcomes of cancer patients after ICU admission: Beyond mortality data
Presenter: Marta Garcia De Herreros
Session: ePoster Display
1107P - Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601)
Presenter: Jaume Capdevila
Session: ePoster Display
1174P - Preliminary prediction of EGFR-mutant non-small cell lung cancer outcome using radiomic signature
Presenter: Jose Minatta
Session: ePoster Display
Resources:
Abstract
1175P - Predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated on the Pacific regimen
Presenter: Robert Gao
Session: ePoster Display
1205P - Treatment sequencing and duration of subsequent tyrosine kinase inhibitors in ALK+ non-small cell lung cancer patients treated with brigatinib in the US
Presenter: Mohammad Jahanzeb
Session: ePoster Display
1456P - Impact of early palliative care in quality at the end of life in small cell lung cancer patients
Presenter: Nicolás Jiménez-García
Session: ePoster Display
1457P - The end-of-life experiences for cancer patients with COVID-19 across the two peak pandemic waves
Presenter: Philippa Mcfarlane
Session: ePoster Display
1668TiP - Phase Ib study of AMG 757, a half-life extended bispecific T-cell engager immuno-oncology therapy, combined with AMG 404, an anti-PD-1 antibody, in patients with small cell lung cancer (SCLC)
Presenter: Afshin Dowlati
Session: ePoster Display
1861P - Development and external validation of a novel TARGET-based prognostic nomogram for children with neuroblastoma
Presenter: Jiajian Hu
Session: ePoster Display